PLoS One, ISSN 1932-6203, 2014, Volume 9, p. e89639
Temporary cART during primary HIV-infection (PHI) did not select for drug resistance mutations after treatment interruption and did not affect the subsequent...
Journal Article
Plos Medicine, ISSN 1549-1676, 2015, Volume 12, Issue 3, pp. e1001809 - e1001809
BACKGROUND: Chronic kidney disease (CKD) is a major health issue for HIV-positive individuals, associated with increased morbidity and mortality. Development...
INDIVIDUALS | GLOMERULAR-FILTRATION-RATE | MEDICINE, GENERAL & INTERNAL | POSITIVE PERSONS | PROTEINURIA | ANTIRETROVIRAL THERAPY | ASSOCIATION | STAGE RENAL-DISEASE | LIFE EXPECTANCY | EXPOSURE | PREDICTION | Kidney - drug effects | Prospective Studies | Age Factors | Kidney - pathology | Renal Insufficiency, Chronic - etiology | Risk Assessment | Comorbidity | HIV Seropositivity - complications | Anti-HIV Agents - adverse effects | Humans | Middle Aged | Male | Risk | CD4 Lymphocyte Count | Incidence | Renal Insufficiency, Chronic - epidemiology | HIV | Clinical Decision-Making | HIV Infections - complications | Sex Factors | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Index Medicus | Life Sciences | Human health and pathology | Santé publique et épidémiologie | Infectious diseases | Urology and Nephrology | Hypertension | Antiretroviral drugs | Mortality | Cardiovascular disease | Infections | Studies | Hepatitis | Data collection | Human immunodeficiency virus | Diabetes | Kidney diseases | Drug use
INDIVIDUALS | GLOMERULAR-FILTRATION-RATE | MEDICINE, GENERAL & INTERNAL | POSITIVE PERSONS | PROTEINURIA | ANTIRETROVIRAL THERAPY | ASSOCIATION | STAGE RENAL-DISEASE | LIFE EXPECTANCY | EXPOSURE | PREDICTION | Kidney - drug effects | Prospective Studies | Age Factors | Kidney - pathology | Renal Insufficiency, Chronic - etiology | Risk Assessment | Comorbidity | HIV Seropositivity - complications | Anti-HIV Agents - adverse effects | Humans | Middle Aged | Male | Risk | CD4 Lymphocyte Count | Incidence | Renal Insufficiency, Chronic - epidemiology | HIV | Clinical Decision-Making | HIV Infections - complications | Sex Factors | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Index Medicus | Life Sciences | Human health and pathology | Santé publique et épidémiologie | Infectious diseases | Urology and Nephrology | Hypertension | Antiretroviral drugs | Mortality | Cardiovascular disease | Infections | Studies | Hepatitis | Data collection | Human immunodeficiency virus | Diabetes | Kidney diseases | Drug use
Journal Article
AIDS (London, England), ISSN 0269-9370, 2008, Volume 22, Issue 16, pp. 2143 - 2153
OBJECTIVE: To evaluate deaths from AIDS-defining malignancies (ADM) and non-AIDS-defining malignancies (nADM) in the D:A:D Study and to investigate the...
D:A:D study | Non-AIDS-defining malignancies | AIDS-defining malignancies | HIV infection | Mortality | UNITED-STATES | CELLS | INFECTIOUS DISEASES | VIRUS | DEATH | IMMUNOLOGY | LIVER-DISEASE | non-AIDS-defining malignancies | VIROLOGY | HEPATITIS | ERA | ACTIVE ANTIRETROVIRAL THERAPY | mortality | CANCER-RISK | INFECTED PATIENTS | Age Factors | Drug Administration Schedule | Humans | Middle Aged | Neoplasms - mortality | Male | CD4 Lymphocyte Count | Lymphoma, AIDS-Related - immunology | Anti-HIV Agents - administration & dosage | Young Adult | HIV Infections - immunology | Lymphoma, AIDS-Related - mortality | Neoplasms - virology | Epidemiologic Methods | Neoplasms - immunology | HIV Infections - complications | Sex Factors | Adult | Female | HIV Infections - drug therapy | HIV Infections - mortality | Aged | Immunocompromised Host | Homosexuality, Male - statistics & numerical data
D:A:D study | Non-AIDS-defining malignancies | AIDS-defining malignancies | HIV infection | Mortality | UNITED-STATES | CELLS | INFECTIOUS DISEASES | VIRUS | DEATH | IMMUNOLOGY | LIVER-DISEASE | non-AIDS-defining malignancies | VIROLOGY | HEPATITIS | ERA | ACTIVE ANTIRETROVIRAL THERAPY | mortality | CANCER-RISK | INFECTED PATIENTS | Age Factors | Drug Administration Schedule | Humans | Middle Aged | Neoplasms - mortality | Male | CD4 Lymphocyte Count | Lymphoma, AIDS-Related - immunology | Anti-HIV Agents - administration & dosage | Young Adult | HIV Infections - immunology | Lymphoma, AIDS-Related - mortality | Neoplasms - virology | Epidemiologic Methods | Neoplasms - immunology | HIV Infections - complications | Sex Factors | Adult | Female | HIV Infections - drug therapy | HIV Infections - mortality | Aged | Immunocompromised Host | Homosexuality, Male - statistics & numerical data
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 05/2018, Volume 66, Issue 9, pp. 1352 - 1359
markdownabstractBackground The Netherlands has provided unrestricted access to direct-acting antivirals (DAAs) since November 2015. We analyzed the nationwide...
Treatment uptake | HIV/HCV coinfection | Direct-acting antivirals | treatment uptake | INFECTIOUS DISEASES | EFFICACY | SAFETY | SEX | MICROBIOLOGY | IMMUNOLOGY | direct-acting antivirals | INDIVIDUALS | HIV | REINFECTION | MEN | INFECTION | COHORT | AMSTERDAM
Treatment uptake | HIV/HCV coinfection | Direct-acting antivirals | treatment uptake | INFECTIOUS DISEASES | EFFICACY | SAFETY | SEX | MICROBIOLOGY | IMMUNOLOGY | direct-acting antivirals | INDIVIDUALS | HIV | REINFECTION | MEN | INFECTION | COHORT | AMSTERDAM
Journal Article
PLoS medicine, ISSN 1549-1277, 2015, Volume 12, Issue 11, p. e1001898; discussion e1001898
The HIV-1 subtype B epidemic amongst men who have sex with men (MSM) is resurgent in many countries despite the widespread use of effective combination...
MEDICINE, GENERAL & INTERNAL | TRANSMISSION | AMERICA | ANTIRETROVIRAL THERAPY | INFERENCE | ALIGNMENTS | Models, Theoretical | Epidemics | Markov Chains | Age Distribution | HIV Infections - epidemiology | Humans | Netherlands - epidemiology | Male | Phylogeny | HIV-1 - genetics | Likelihood Functions | Epidemiological Monitoring | Base Sequence | Adult | HIV Infections - transmission | Homosexuality, Male - statistics & numerical data | Monte Carlo Method | Cohort Studies | Antiviral agents | Highly active antiretroviral therapy | Care and treatment | Cladistic analysis | Analysis | Diagnosis | HIV (Viruses) | AIDS | Disease transmission | Human immunodeficiency virus | HIV | Acquired immune deficiency syndrome
MEDICINE, GENERAL & INTERNAL | TRANSMISSION | AMERICA | ANTIRETROVIRAL THERAPY | INFERENCE | ALIGNMENTS | Models, Theoretical | Epidemics | Markov Chains | Age Distribution | HIV Infections - epidemiology | Humans | Netherlands - epidemiology | Male | Phylogeny | HIV-1 - genetics | Likelihood Functions | Epidemiological Monitoring | Base Sequence | Adult | HIV Infections - transmission | Homosexuality, Male - statistics & numerical data | Monte Carlo Method | Cohort Studies | Antiviral agents | Highly active antiretroviral therapy | Care and treatment | Cladistic analysis | Analysis | Diagnosis | HIV (Viruses) | AIDS | Disease transmission | Human immunodeficiency virus | HIV | Acquired immune deficiency syndrome
Journal Article